{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=28232&min-ddpCreated=2015-06-16T21%3A34%3A51.830Z&max-date=2018-07-23", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?identifier=28232&min-ddpCreated=2015-06-16T21%3A34%3A51.830Z&max-date=2018-07-23", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=28232&min-ddpCreated=2015-06-16T21%3A34%3A51.830Z&max-date=2018-07-23&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=28232&_page=0&min-ddpCreated=2015-06-16T21%3A34%3A51.830Z&max-date=2018-07-23", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=28232&min-ddpCreated=2015-06-16T21%3A34%3A51.830Z&max-date=2018-07-23", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=28232&min-ddpCreated=2015-06-16T21%3A34%3A51.830Z&max-date=2018-07-23", "items" : [{"_about" : "http://data.parliament.uk/resources/454866", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/454866/answer", "answerText" : {"_value" : "
National immunisation programmes are introduced on the advice of the Joint Committee on Vaccination and Immunisation (JCVI), the independent expert body that advises the Government on all immunisation matters. JCVI\u2019s recommendations are based on a comprehensive and careful review of a wide range of evidence including information from medical experts.<\/p>
<\/p>
JCVI reviewed the available evidence on meningitis B vaccine and recommended a national Meningococcal B (MenB) immunisation programme for infants. The MenB vaccine is first offered to babies at 2 months of age, with further doses offered when they reach 4 and 12 months of age.<\/p>
<\/p>
MenB was introduced into the NHS programme in September 2015. JCVI keeps the eligibility criteria of all vaccination programmes under review and considers new evidence as it becomes available. If JCVI provides further advice about the programme, we will consider this.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2016-02-29", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "28230"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-02-29T18:21:57.777Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2016-02-24", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Meningitis: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, when his Department last consulted medical authorities on the potential merits of making the meningitis B vaccine available on the NHS for all children; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/316", "label" : {"_value" : "Biography information for Mr David Winnick"} } , "tablingMemberConstituency" : {"_value" : "Walsall North"} , "tablingMemberPrinted" : [{"_value" : "Mr David Winnick"} ], "uin" : "28232"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }